NCT06358625
- Conditions
- HER2-positive Breast Cancer, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- Centre de lutte contre le cancer Eugène Marquis Rennes, France
Clinical trial condition
HER2-positive Breast Cancer
Explore clinical trials studying HER2-positive Breast Cancer. Study availability and eligibility vary by location and protocol.
207 public trials
81 recruiting studies
HER2-positive Breast Cancer trial results
NCT07073755
- Conditions
- Breast Diseases, Breast Neoplasms, Drug Resistance, +10 more
- Locations
-
- Hunan Cancer Hospital Changsha, Hunan, China
- Conditions
- HER2-positive Breast Cancer
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China, 200032 Shanghai, Shanghai Municipality, China
NCT07030569
- Conditions
- Breast Cancer, Breast Cancer Metastatic, Breast Cancer Stage IV, +18 more
- Locations
-
- Fondazione IRCCS Istituto Nazionale Tumori Milan, Italy
Recruiting
Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer
NCT05406635
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +7 more
- Locations
-
- Aalborg University Hospital Aalborg, Denmark
- Rigshospitalet Copenhagen, Denmark
- Herlev University Hospital Herlev, Denmark
- Odense University Hospital Odense, Denmark
NCT05955170
- Conditions
- HER2-positive Breast Cancer
- Locations
-
- Centre Jean Perrin Clermont-Ferrand, Clermont Ferrand, France
- CHU Amiens Picardie-Site Sud Amiens, France
- Institut Sainte Catherine Avignon, France
- Centre François Baclesse Caen, France
NCT05918328
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- Henan cancer hospital Zhengzhou, Henan, China
Recruiting
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
NCT05020860
- Conditions
- Breast Cancer, Breast Cancer Female, Breast Cancer Invasive, +14 more
- Locations
-
- Harris Health System - Smith Clinic Houston, Texas, United States
- O'Quinn Medical Tower - McNair Campus - Dan L Duncan Comprehensive Cancer Center Houston, Texas, United States
NCT06832904
- Conditions
- HER2-positive Breast Cancer, Neoadjuvant Therapy, Pyrotinib
- Locations
-
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China
Recruiting
Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual Disease
NCT05388149
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- University Health Network: Princess Margaret Cancer Centre Toronto, Ontario, Canada